• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腋窝与手腕作为乳腺癌相关性淋巴水肿的血管化淋巴结转移受区的比较:系统评价和荟萃分析。

Axilla versus Wrist as the Recipient Site in Vascularized Lymph Node Transfer for Breast Cancer-Related Lymphedema: A Systematic Review and Meta-Analysis.

机构信息

Division of Plastic and Reconstructive Surgery, Department of Surgery, McGill University, Montreal, Quebec, Canada.

Faculty of Medicine, McGill University, Montreal, Quebec, Canada.

出版信息

J Reconstr Microsurg. 2022 Sep;38(7):539-548. doi: 10.1055/s-0041-1740132. Epub 2021 Dec 7.

DOI:10.1055/s-0041-1740132
PMID:34875698
Abstract

BACKGROUND

Vascularized lymph node transfers (VLNT) are being used with increasing frequency for the treatment of breast cancer-related lymphedema (BCRL). However, there is a lack of consensus in the surgical field as to which recipient site should be utilized. We, therefore, aim to assess the evidence comparing the wrist and axilla as recipient sites for VLNT in BCRL.

METHODS

We conducted a systematic literature review to compare the wrist and axilla as recipient sites for VLNT in BCRL. Demographic data, as well as circumference reduction rate (CRR), excess volume reduction (EVR), postoperative decrease in infections per year, postoperative discontinuation of compression garments, and overall pooled complication rate were extracted from included studies. These were compared through a meta-analysis.

RESULTS

A total of 37 studies met the inclusion criteria for a total of 689 patients. VLNTs to the wrist and axilla resulted in a decrease in CRR of 42.1 and 51.5%, and a decrease in EVR of 35.6 and 48.8%, respectively. However, our meta-analysis showed no significant differences between CRR or EVR and between wrist and axilla as recipient sites. Similarly, we found no differences in postoperative decrease in infections per year, postoperative discontinuation of compression garments, and overall pooled complication rate.

CONCLUSION

These data suggest noninferiority between the wrist and axilla as recipient sites for VLNT in the context of BCRL. In the absence of randomized, prospective data, we hope these results can be used as an evidence-based reference and facilitate future studies.

摘要

背景

带血管化淋巴结转移(VLNT)越来越多地用于治疗乳腺癌相关淋巴水肿(BCRL)。然而,在手术领域,对于应该使用哪个受体部位,尚未达成共识。因此,我们旨在评估比较腕部和腋窝作为 BCRL 中 VLNT 受体部位的证据。

方法

我们进行了一项系统的文献综述,以比较腕部和腋窝作为 BCRL 中 VLNT 的受体部位。从纳入的研究中提取了人口统计学数据,以及周长减少率(CRR)、多余体积减少率(EVR)、每年术后感染减少量、术后停止使用压缩衣和总体汇总并发症发生率。通过荟萃分析比较了这些数据。

结果

共有 37 项研究符合纳入标准,共 689 名患者。VLNT 至腕部和腋窝分别导致 CRR 降低 42.1%和 51.5%,EVR 降低 35.6%和 48.8%。然而,我们的荟萃分析表明,CRR 或 EVR 以及腕部和腋窝作为受体部位之间没有显著差异。同样,我们发现每年术后感染减少量、术后停止使用压缩衣和总体汇总并发症发生率没有差异。

结论

这些数据表明,在 BCRL 背景下,VLNT 的腕部和腋窝受体部位之间具有非劣效性。在缺乏随机、前瞻性数据的情况下,我们希望这些结果可以作为循证参考,并促进未来的研究。

相似文献

1
Axilla versus Wrist as the Recipient Site in Vascularized Lymph Node Transfer for Breast Cancer-Related Lymphedema: A Systematic Review and Meta-Analysis.腋窝与手腕作为乳腺癌相关性淋巴水肿的血管化淋巴结转移受区的比较:系统评价和荟萃分析。
J Reconstr Microsurg. 2022 Sep;38(7):539-548. doi: 10.1055/s-0041-1740132. Epub 2021 Dec 7.
2
Comparing Different Donor Sites After Vascularized Lymph Node Transfer to the Lymphedematous Upper Limb: A Systematic Review and Meta-analysis of Clinical Outcomes.比较血管化淋巴结移植治疗上肢淋巴水肿后不同供区:临床结局的系统评价和荟萃分析。
Ann Plast Surg. 2024 Jul 1;93(1):130-138. doi: 10.1097/SAP.0000000000003918.
3
Orthotopic vascularized lymph node transfer in breast cancer-related lymphedema treatment: Functional and life quality outcomes.原位带血管淋巴结转移术治疗乳腺癌相关淋巴水肿:功能及生活质量结果
Microsurgery. 2024 Feb;44(2):e31147. doi: 10.1002/micr.31147.
4
Improving quality of life after breast cancer: a comparison of two microsurgical treatment options for breast cancer-related lymphedema (BCRL).改善乳腺癌后的生活质量:两种针对乳腺癌相关淋巴水肿(BCRL)的显微外科治疗方案的比较。
Clin Exp Med. 2024 Apr 23;24(1):82. doi: 10.1007/s10238-024-01344-w.
5
Vascularized Lymph Node Transfer for Patients with Breast Cancer-Related Lymphedema Can Potentially Reduce the Burden of Ongoing Conservative Management.乳腺癌相关淋巴水肿患者的血管化淋巴结转移可能会降低持续保守治疗的负担。
Lymphat Res Biol. 2020 Aug;18(4):357-364. doi: 10.1089/lrb.2019.0048. Epub 2020 Jan 16.
6
A systematic review and meta-analysis of vascularized lymph node transfer for breast cancer-related lymphedema.血管化淋巴结转移治疗乳腺癌相关淋巴水肿的系统评价和荟萃分析。
J Vasc Surg Venous Lymphat Disord. 2022 May;10(3):786-795.e1. doi: 10.1016/j.jvsv.2021.08.023. Epub 2021 Sep 8.
7
Orthotopic transfer of vascularized groin lymph node flap in the treatment of breast cancer-related lymphedema: Clinical results, lymphoscintigraphy findings, and proposed mechanism.带血管蒂腹股沟淋巴结瓣原位转移治疗乳腺癌相关淋巴水肿:临床结果、淋巴闪烁造影结果及提出的机制
J Plast Reconstr Aesthet Surg. 2018 Jul;71(7):1033-1040. doi: 10.1016/j.bjps.2018.02.015. Epub 2018 Feb 28.
8
Microsurgical techniques in the treatment of breast cancer-related lymphedema: a systematic review of efficacy and patient outcomes.显微外科技术治疗乳腺癌相关淋巴水肿:疗效及患者预后的系统评价
Breast Cancer. 2021 Sep;28(5):1002-1015. doi: 10.1007/s12282-021-01274-5. Epub 2021 Jul 12.
9
Clinical and Psychosocial Outcomes of Vascularized Lymph Node Transfer for the Treatment of Upper Extremity Lymphedema After Breast Cancer Therapy.血管化淋巴结转移治疗乳腺癌术后上肢淋巴水肿的临床和心理社会结局
Ann Surg Oncol. 2017 Jun;24(6):1475-1481. doi: 10.1245/s10434-016-5614-4. Epub 2016 Oct 12.
10
Combining reconstructive and ablative surgical treatment of chronic breast cancer-related lymphedema (BCRL): safe and effective.重建和破坏手术联合治疗慢性乳腺癌相关淋巴水肿(BCRL):安全有效。
Breast Cancer Res Treat. 2023 Jan;197(1):83-92. doi: 10.1007/s10549-022-06778-y. Epub 2022 Oct 26.

引用本文的文献

1
[Single-stage treatment of upper limb lymphedema following breast cancer surgery using superficial circumflex iliac artery perforator-based vascularized lymph node transfer combined with lymphaticovenular anastomosis and liposuction].[采用基于旋髂浅动脉穿支的带血管蒂淋巴结转移联合淋巴管静脉吻合及抽脂术对乳腺癌术后上肢淋巴水肿进行单阶段治疗]
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2025 Sep 15;39(9):1114-1121. doi: 10.7507/1002-1892.202506113.
2
Surgical treatment of breast cancer related lymphedema-the combined approach: a literature review.乳腺癌相关淋巴水肿的外科治疗——联合治疗方法:文献综述
Gland Surg. 2023 Dec 26;12(12):1746-1759. doi: 10.21037/gs-23-247. Epub 2023 Dec 22.
3
Surgical management of breast cancer-related lymphedema: a narrative review of contemporary practices.
乳腺癌相关淋巴水肿的外科治疗:当代实践的叙述性综述
Ann Transl Med. 2023 Dec 20;11(12):418. doi: 10.21037/atm-23-292. Epub 2023 Oct 16.
4
[Research progress of combined surgical treatment of lymphedema based on vascularized lymph node transfer].基于带血管蒂淋巴结转移术的淋巴水肿联合手术治疗研究进展
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2023 Feb 15;37(2):240-246. doi: 10.7507/1002-1892.202210009.
5
What do we know about treating breast-cancer-related lymphedema? Review of the current knowledge about therapeutic options.我们对治疗乳腺癌相关性淋巴水肿有哪些了解?对治疗选择的现有知识进行综述。
Breast Cancer. 2023 Mar;30(2):187-199. doi: 10.1007/s12282-022-01428-z. Epub 2022 Dec 26.